Andrew Tan
Papers
3
Total Citations
103
H-Index
3
About
Andrew Tan is a leading urological surgeon and researcher whose work centers on advancing minimally invasive treatments for benign prostatic hyperplasia (BPH). His most significant contribution is his pioneering role in the development and clinical validation of aquablation—an innovative, image-guided, robot-assisted water jet ablation technology for the prostate. Tan was a principal investigator in the landmark multicenter trial that established the safety and effectiveness of this procedure, with the 1-year results published in 2017 accumulating 88 citations. This work has positioned aquablation as a transformative alternative to traditional surgical approaches, offering precise tissue removal with reduced side effects. Additionally, Tan contributed to the analysis of Australia’s large-scale laparoscopic radical prostatectomy experience, examining outcomes from nearly 3,000 cases performed by fellowship-trained surgeons. His research bridges cutting-edge robotic technology with rigorous clinical evidence, directly impacting surgical practice and patient quality of life. As a key figure in the evolution of BPH management, Tan’s work continues to shape the future of urological surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3